First, although a number of clinical and social factors probably account for the excess of comorbid somatic illnesses in patients with severe mental disorders (eg, symptoms, medication, lifestyle, and limited access to health care services), associations may also be partly due to specific biologic overlaps at the genetic and molecular level between disorders that at first instance are considered to be distinct. For example, underlying genetic vulnerabilities may explain the comorbidities of asthma with mental disorders 2 or migraine with other conditions such as endometriosis. 3, 4 Second, in contrast with co-occurrence, few population-based studies have explored in detail the "negative" or "inverse" comorbidity in psychiatric and medical disorders (ie, a lower than expected probability of occurrence of diseases) ( Table 1 ). It is intriguing that 2 rigorous population-based studies 5, 6 and the first meta-analysis of cancer incidence rates 7 found a significantly lower risk of respiratory and prostate cancer in people with schizophrenia and their relatives compared with people without schizophrenia after adjusting for confounding variables. Moreover, schizophrenia is associated with tobacco smoking, the most studied risk factor for lung cancer. Lung and prostate cancers are associated with the highest numbers of deaths from cancer around the world, according to the World Health Organization. 8 Although alternative explanations may be invoked (ie, biases arising from difficulties in adjusting for confounders or competing risks, cancer-protective effect of antipsychotic medications, obstetric complications, and lifestyle differences), we propose that the genetic predisposition toward schizophrenia might confer genetically reduced susceptibility to lung and prostate cancer. 9 This is akin to the observation that individuals with young-adult-onset Hodgkin lymphoma are less likely to have a personal or family history of diabetes mellitus. Another finding is the reduced occurrence of rheumatoid arthritis in people with schizophrenia and in people with multiple sclerosis.
Comorbidity represents a significant opportunity to understand the biologic connections among disorders. Moreover, epidemiologic data suggest that negative comorbidity may be a valuable model for investigating common or related pathways or processes and testing new therapies. In fact, modulation of the dopaminergic system has been suggested as a new target for cancer therapy. Prostate cancer a Data were identified by a systematic review using the MEDLINE database, supplemented with a manual search of reference lists. The diagnostic terms schizophrenia, bipolar disorder or manic-depression, depression, diabetes, and multiple sclerosis were combined with keywords indicating a populationbased register study. Abbreviation: HIV = human immunodeficiency virus.
